Kuznicki Law PLLC notifies investors that a class action has commenced in the United States District Court for the Northern District of Ohio on behalf of shareholders of Sotera Health Company (NasdaqGS: SHC), if they purchased or otherwise acquired the Company’s shares (i) pursuant and/or traceable to the Company’s November 2020 initial public offering (the “IPO”); (ii) pursuant and/or traceable to the Company’s March 2021 secondary public offering (the “SPO,” and together with the IPO, the “Offerings”); and/or (iii) between November 20, 2020 and September 19, 2022, inclusive (the “Class Period”).
Sotera and certain of its executives are charged with failing to disclose material information during the Class Period and/or in the Registration Statement and Prospectus issued in conjunction with the Offerings, violating federal securities laws.
On September 19, 2022, a jury presiding over the first lawsuit against the Company to go to trial arising from the Company’s Ethylene Oxide (“EtO”) emissions held it liable for “willful and wanton” misconduct in failing to prevent toxic EtO emissions and failing to warn about the severe health hazard posed by them, which caused the plaintiff’s cancer condition.
On this news, the price of Sotera’s shares plummeted, falling by $4.90 per share or approximately 33.3%.
If you wish to choose counsel to represent you and the class, you must apply to be appointed lead plaintiff and be selected by the Court. The lead plaintiff will direct the litigation and participate in important decisions including whether to accept a settlement for the class in the action. The lead plaintiff will be selected from among applicants claiming the largest loss from investment in the respective securities during the class periods. Members of the class will be represented by the lead plaintiff and counsel chosen by the lead plaintiff. No class has yet been certified in the above action. Appointment as Lead Plaintiff is not required to partake in any recovery.
Shareholders have until March 27, 2023 to request that the court appoint them lead plaintiff.